Vivet Therapeutics is pleased to announce that our CEO, Jean-Philippe Combal, will be attending the Jefferies Global Healthcare Conference in London from November 18th to 20th, 2025. As we join this leading global event, we are excited to present our latest advances, including the VTX-PID NAb depleting strategy. VTX-PID is designed to temporarily reduce anti-AAV neutralizing antibodies, allowing for safe and effective AAV-based gene therapy even in individuals who previously had inhibitory antib
Tuesday, November 18, 2025 - Thursday, November 20, 2025
Vivet Therapeutics is pleased to announce that our CEO, Jean-Philippe Combal, will be attending the Jefferies Global Healthcare Conference in London from November 18th to 20th, 2025. As we join this leading global event, we are excited to present our latest advances, including the VTX-PID NAb depleting strategy. VTX-PID is designed to temporarily reduce anti-AAV neutralizing antibodies, allowing for safe and effective AAV-based gene therapy even in individuals who previously had inhibitory antib
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial βVIVET THERAPEUTICS ATTENDING JEFFERIES 2025 β LONDON HEALTHCARE CONFERENCE takes place on Tuesday, November 18, 2025 to Thursday, November 20, 2025.
VIVET THERAPEUTICS ATTENDING JEFFERIES 2025 β LONDON HEALTHCARE CONFERENCE is held in London.
Pricing information is available on the event website.
VIVET THERAPEUTICS ATTENDING JEFFERIES 2025 β LONDON HEALTHCARE CONFERENCE is designed for healthcare professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox